Source: Hanson L / Shutterstock.com
Emergent BioSolutions (NYSE:EBS) just reported results for the first quarter of 2024.
- Emergent BioSolutions reported earnings per share of 59 cents. This was above the analyst estimate for EPS of -83 cents.
- The company reported revenue of $300.40 million.
- This was 33.81% better than the analyst estimate for revenue of $224.50 million.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/ebs-stock-earnings-emergent-biosolutions-for-q1-of-2024/.
©2024 InvestorPlace Media, LLC